Flagship Pioneering’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $62M | Hold |
|
|||||
|
2025
Q2 | $59.6M | Hold |
|
|||||
|
2025
Q1 | $46.3M | Hold |
|
|||||
|
2024
Q4 | $59.8M | Hold |
|
|||||
|
2024
Q3 | $118M | Hold |
|
|||||
|
2024
Q2 | $72.9M | Hold |
|
|||||
|
2024
Q1 | $85M | Hold |
|
|||||
|
2023
Q4 | $81.7M | Hold |
|
|||||
|
2023
Q3 | $63.4M | Hold |
|
|||||
|
2023
Q2 | $89.2M | Hold |
|
|||||
|
2023
Q1 | $78.6M | Hold |
|
|||||
|
2022
Q4 | $80.9M | Hold |
|
|||||
|
2022
Q3 | $109M | Hold |
|
|||||
|
2022
Q2 | $172M | Hold |
|
|||||
|
2022
Q1 | $193M | Hold |
|
|||||
|
2021
Q4 | $290M | Hold |
|
|||||
|
2021
Q3 | $177M | Hold |
|
|||||
|
2021
Q2 | $135M | Hold |
|
|||||
|
2021
Q1 | $167M | Hold |
|
|||||
|
2020
Q4 | $257M | Buy |
|